Home | Welcome to Contract Pharma   
Last Updated Saturday, May 25 2013
Print RSS Feed

Breaking News

Related Searches: Industry News

May 18, 2009
Quotient Bioresearch Ltd. has acquired Charles River Laboratories’ Edinburgh clinical research facility.  Read More »

May 18, 2009
GlaxoSmithKline and Oxford BioTherapeutics have formed a strategic alliance to discover, develop and commercialize novel, therapeutic antibodies for the treatment of primary, metastatic and recurring forms of cancer.  Read More »

May 18, 2009
DSM has announced that its proprietary XD Technology can boost bioreactor productivity and titers of mammalian cell culture processes by 5-10 fold  Read More »

May 15, 2009
SGS Life Science Services expanded its Phase I Unit in Antwerp, Belgium, adding 22 new hospitalization beds to its clinical pharmacology unit in the Stuivenberg hospital.  Read More »

May 15, 2009
Growth in the quarter was driven primarily by 28% growth in revenues for China-based Lab Services to $41.6 million, offset by an 81% decline in manufacturing services revenue.  Read More »

May 15, 2009
Enzon Pharmaceuticals, Inc. received approval from the FDA for Cimzia for the treatment of adult patients with moderately to severely active rheumatoid arthritis (RA).  Read More »

May 14, 2009
Minakem Group has completed the acquisition of AstraZeneca's APIs plant in Dunkirk, France and has signed a long-term supply contract for Budesonide, Omeprazole and Esomeprazole.   Read More »

May 14, 2009
Regulus Therapeutics, Inc. achieved the initial milestone in its worldwide strategic alliance with GlaxoSmithKline to discover, develop and market novel microRNA-based therapeutics to treat inflammatory diseases.  Read More »

May 14, 2009
Microtest Laboratories is adding dissolution testing to its current suite of analytical testing and stability testing services.   Read More »

May 13, 2009
GE Healthcare has launched GE Healthcare Facility Validation Services, a new global service that will provide customers with comprehensive international regulatory compliance for facilities and manufacturing systems compared with complex traditional appro  Read More »

May 13, 2009
Cory Lewis has been named director of business development for the global biopharmaceutical contract development and manufacturing division of Cook Medical.  Read More »

May 13, 2009
Eden Biodesign has completed a successful second audit by the UK Medicines and Healthcare Products Regulatory Agency (MHRA), European Medicines Agency (EMEA) to manufacture Investigational Medicinal Products (IMPs) at its facility in Liverpool, UK.  Read More »

May 12, 2009
GlaxoSmithKline has agreed to extend its strategic relationship with South African-based Aspen Pharmacare Holdings Ltd., and to acquire a 16% share in the company.  Read More »

May 12, 2009
Sanofi-aventis U.S. has acquired commercial rights to Oforta (fludarabine phosphate film-coated tablets), an oral B-cell chronic lymphocytic leukemia (CLL) drug, from biotechnology company Antisoma.  Read More »

May 12, 2009
Sartorius Stedim Biotech expanded its technology portfolio with the addition of two prototypes of single-use bioreactors that operate based on novel mixing technologies.  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On